In Well‐Treated Celiac Patients Low‐Level Mucosal Inflammation Predicts Response to 14‐day Gluten Challenge
Open Access
- 4 January 2021
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 8 (4)
Abstract
In celiac disease (CeD), gluten activates adaptive immune cells that cause damage to the small intestinal mucosa. Histological evaluation of intestinal biopsies allows for grading of disease severity. CeD can effectively be treated with a life‐long gluten‐free diet. Gluten challenge of treated CeD patients is used to confirm diagnosis and to test drug efficacy in clinical trials, but patients respond with different magnitudes to the same gluten challenge. In this study of 19 well‐treated CeD patients, proteome analysis of total tissue or isolated epithelial cell compartment from formalin‐fixed paraffin embedded biopsies collected before and after 14‐day gluten challenge demonstrates that patients with strong mucosal response to challenge have signs of ongoing tissue inflammation already before challenge. This low‐level tissue inflammation at baseline is paralleled by increased gluten specific CD4+ T‐cell frequencies in the gut and presence of a low‐level blood inflammatory profile. Thus, apparently well‐treated CeD is frequently not entirely quiescent, with presence of low‐grade inflammation and antigluten immunity in the gut mucosa. Histology assessment alone appears insufficient to judge full recovery and gut mucosal healing of CeD patients. The findings raise a concern whether a seemingly proper gluten‐free diet is able to curb gut inflammation in all CeD patients.Keywords
Funding Information
- Stiftelsen Kristian Gerhard Jebsen (SKGJ‐MED‐017)
This publication has 15 references indexed in Scilit:
- Characterization of the Small Intestinal Lesion in Celiac Disease by Label-Free Quantitative Mass SpectrometryThe American Journal of Pathology, 2018
- Disease-driving CD4+ T cell clonotypes persist for decades in celiac diseaseJournal of Clinical Investigation, 2018
- Measuring Change In Small Intestinal Histology In Patients With Celiac DiseaseAmerican Journal of Gastroenterology, 2018
- A single-cell survey of the small intestinal epitheliumNature, 2017
- HLA-DQ:gluten tetramer test in blood gives better detection of coeliac patients than biopsy after 14-day gluten challengeGut, 2017
- 2016 update of the PRIDE database and its related toolsNucleic Acids Research, 2015
- Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patientsProceedings of the National Academy of Sciences, 2007
- Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.Journal of Experimental Medicine, 1993
- Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue').1992
- Gluten, major histocompatibility complex, and the small intestineGastroenterology, 1992